Intellia Therapeutics, Inc. Income Statement

Income Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 6.04M16.48M26.12M30.43M43.10M57.99M33.05M52.12M36.27M57.88M
Gross Profit 6.04M16.48M26.12M30.43M43.10M57.99M33.05M52.12M36.27M57.88M
Operating items
Research & Development 11.17M31.84M67.65M89.11M108.41M150.41M229.81M419.98M435.07M466.31M
Selling, General & Administrative 8.28M16.80M28.02M32.19M41.06M44.17M71.10M90.31M116.50M125.83M
Operating Expenses 19.45M48.64M95.67M121.30M149.47M194.58M300.90M510.29M551.57M592.14M
Operating Income -13.41M-32.16M-69.56M-90.87M-106.37M-136.58M-267.85M-458.16M-515.29M-534.26M
EBIT -13.41M-32.16M-69.56M-90.87M-106.37M-136.58M-267.85M-458.16M-515.29M-534.26M
Non-operating items
Non Operating Investment Income -0.03M0.29M-0.26M-2.13M-1.64M3.63M-32.56M
Interest & Investment Income 0.53M2.01M5.53M6.83M2.35M1.28M8.54M49.83M47.81M
Other Non Operating Income 6.83M2.35M-0.04M-16.02M34.10M15.24M
Non Operating Income 6.83M2.35M-0.04M-16.02M34.10M15.24M
Net income details
EBT -13.41M-31.63M-67.54M-85.34M-99.53M-134.23M-266.57M-449.62M-465.46M-486.46M
Tax Provisions -1.01M
Profit After Tax -12.40M-31.63M-67.54M-85.34M-99.53M-134.23M-267.89M-474.19M-481.19M-519.02M
Equity Income -1.32M-11.08M-15.63M
Income from Continuing Operations -12.40M-31.63M-67.54M-85.34M-99.53M-134.23M-266.57M-449.62M-465.46M-486.46M
Consolidated Net Income -12.40M-31.63M-67.54M-85.34M-99.53M-134.23M-266.57M-449.62M-465.46M-486.46M
Income towards Parent Company -12.40M-31.63M-67.54M-85.34M-99.53M-134.23M-266.57M-449.62M-465.46M-486.46M
Net Income towards Common Stockholders -12.40M-31.63M-67.54M-85.34M-99.53M-134.23M-266.57M-449.62M-465.46M-486.46M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 34.28M36.00M36.09M43.42M48.88M59.08M74.42M78.68M89.55M101.85M
Shares Outstanding (Diluted Average) 55.99M70.89M76.97M88.77M98.85M
EBITDA -13.41M-31.63M-67.54M-85.37M-99.24M-134.49M-270.52M-479.01M-475.99M-518.29M
Tax Rate 0.00M